Clinical study of a new anti-inflammatory drug: 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370)
- PMID: 4553235
Clinical study of a new anti-inflammatory drug: 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370)
Similar articles
-
Clinical trial of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in painful osteoarticular conditions.Arzneimittelforschung. 1972 Jan;22(1):Suppl 1a:262-5. Arzneimittelforschung. 1972. PMID: 4553234 Clinical Trial. No abstract available.
-
Metabolic and clinical effects of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370).Arzneimittelforschung. 1972 Jan;22(1):Suppl 1a:268-7. Arzneimittelforschung. 1972. PMID: 5067203 No abstract available.
-
Clinical and laboratory evaluation of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370) in rheumatoid arthritis and ankylosing spondylitis.Arzneimittelforschung. 1972 Jan;22(1):Suppl 1a:253-8. Arzneimittelforschung. 1972. PMID: 4553232 Clinical Trial. No abstract available.
-
[Pharmacodynamics and adverse effects of modern nonsteroid anti-inflammatory agents].Ter Arkh. 1981;53(7):142-51. Ter Arkh. 1981. PMID: 6457407 Review. Russian. No abstract available.
-
Ibuprofen. A review.Practitioner. 1971 Nov;207(241):639-43. Practitioner. 1971. PMID: 4944128 Review. No abstract available.
Cited by
-
Feprazone, a new anti-inflammatory agent. Studies of potency and gastrointestinal tolerance.Ann Rheum Dis. 1975 Apr;34(2):190-4. doi: 10.1136/ard.34.2.190. Ann Rheum Dis. 1975. PMID: 1094965 Free PMC article. Clinical Trial.